Cutaneous Manifestations of Internal Malignancy
Journal Title: International Journal of Contemporary Medical Research - Year 2017, Vol 4, Issue 4
Abstract
Malignancy inside the human body manifests as cutaneous disorders which a person was not aware of. Many of the Dermatological lesions are overseen by dermatologists and dentists in the diagnosis of various autoimmune disorders like systemic lupus erythematosus, Pemphigus and Photosensitivity and drug mediated hypersensitivity reactions. Hence the need for diagnosis of cutaneous manifestations proves a challenge to dermatologists and also dentists. This article enlightens some cutaneous manifestations that can occur in Patients with underlying internal malignancy.
Authors and Affiliations
Karthik R, Mohan N, Ravi Kumar PT, Saramma Mathew Fenn
Changing Trends in Genital Ulcer of Patients Attending Sexually Transmitted Infection (STI) Clinic in a Tertiary Care Centre of North Eastern India - A Retrospective Study of 10 Years
Introduction: Sexually transmitted genital ulcer disease (GUD) form a major part of the burden of sexually transmitted diseases and increase the chance of transmission of human immunodeficiency virus (HIV). Study objecti...
Study of Autonomic Variation of Heart Rate in Middle Aged Diabetics
Introduction: The Back ground of this study is thatthe number of patients with diabetes in India is currently around 40.9 million and is expected to rise to 101 million by 2030. It is estimated that almost one in six peo...
Outpatient based Video EEG Monitoring and Outcome A Step towards Epilepsy Surgery
Introduction: The central role in the diagnosis of the epilepsy is played by electroencephalogram (EEG). Also, in India, there exists a large treatment gap as appropriate treatment for the condition is not received by th...
Cortisol Levels in Healthy Term and Preterm Appropriate for Gestation Infants
Introduction: Cortisol levels in term and preterm neonates are affected by various factors namely gestational age, postnatal age, sickness and antenatal steroids. There is no normative data on cross-sectional values of s...
Deadly Combination; Ti̇kagrelor and Abciximab
Introduction: Incremental improvements in pharmacotherapy for percutaneous coronary intervention continue to reduce the incidence of adverse clinical events for the treatment of both stable coronary artery disease and ac...